SCHEMBL5720575

SCHEMBL5720575

CCOC(=O)Nc1cc(S(=O)(=O)O)c2c(O)ccc(S(=O)(=O)O)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ ALDH1A1 P00352 6/20 0.41
▸ HSD17B10 Q99714 4/20 0.41
▸ LMNA P02545 2/20 0.41
▸ RECQL P46063 1/20 0.41
▸ MAPK1 P28482 2/20 0.40
▸ MAPT P10636 1/20 0.40
▸ HPGD P15428 5/20 0.40
▸ RAB9A P51151 4/20 0.40
▸ CYP2C9 P11712 4/20 0.40
▸ CYP2C19 P33261 4/20 0.40
▸ CYP1A2 P05177 3/20 0.40
▸ CYP2D6 P10635 3/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ SENP8 Q96LD8 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10393697 0.82 ENPP2 (0.47) ALDH1A1HSD17B10LMNARECQLMAPT
SCHEMBL10604369 0.82 TIMP3 (0.49) ALDH1A1HSD17B10RECQLMAPTCYP1A2
SCHEMBL5720597 0.78 NT5E (0.43) POLBKDM4ESMN1; SMN2ALDH1A1HSD17B10
SCHEMBL5720569 0.76 TIMP3 (0.46) POLBSMN1; SMN2ALDH1A1HSD17B10LMNA
SCHEMBL9350837 0.75 TIMP3 (0.49) SMN1; SMN2ALDH1A1HSD17B10LMNARECQL
SCHEMBL5720540 0.73 NT5E (0.65) POLBSMN1; SMN2ALDH1A1HSD17B10LMNA
SCHEMBL8591780 0.73 SMN1; SMN2 (0.49) POLBKDM4ESMN1; SMN2ALDH1A1HSD17B10
SCHEMBL8590541 0.73 CTDSP1 (0.59) POLBKDM4ESMN1; SMN2ALDH1A1HSD17B10
SCHEMBL5720558 0.72 KDM4E (0.45) POLBKDM4ESMN1; SMN2ALDH1A1HSD17B10
SCHEMBL11767621 0.70 KDM4E (0.70) POLBKDM4ESMN1; SMN2ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060229440-A1 Disazo dyes, and copper complexes thereof, for dyeing paper KASER ADOLF 2006-10-12 — — US disclosed
US-7078497-B2 Disazo dyes, and copper complexes thereof, for dyeing paper CIBA SPECIALTY CHEMICALS CORPORATION (US) 2006-07-18 — — US disclosed
EP-1345992-B1 DISAZO DYES, AND COPPER COMPLEXES THEREOF, FOR DYEING PAPER CIBA SC HOLDING AG (CH) 2006-07-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229440-A1 Disazo dyes, and copper complexes thereof, for dyeing paper AOC1, SOD1, AOC3 POLB 2424/4885KDM4E 3335/4885SMN1; SMN2 3958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback